Very low-dose methotrexate in the treatment of GVHD in children

Abstract

Acute GVHD is an important clinical problem frequently encountered in relation to stem cell transplantation. In its initial treatment glucocorticoids remain the established drug of choice. In the face of the side-effects related to therapy with glucocorticoids other, possibly less toxic, options for the initial treatment of acute GVHD might be of use. We report the successful treatment of progressive cutaneous acute GVHD up to grade II in five pediatric recipients of unrelated marrow grafts.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vettenranta, K., Hovi, L., Parto, K. et al. Very low-dose methotrexate in the treatment of GVHD in children. Bone Marrow Transplant 20, 75–77 (1997). https://doi.org/10.1038/sj.bmt.1700846

Download citation

Keywords

  • low-dose methotrexate
  • GVHD
  • children

Further reading